Smith+Nephew develops and sells the CORI Surgical System, a robotic-assisted platform for orthopedic surgery. Its medical robotics business qualifies as a medical and surgical robotics system.
Smith+Nephew's CORI handheld robotic platform (within the LSE:SN group) covers revision knee, hip, and shoulder procedures in hospital and ASC settings, with CORI XT first clinical cases in June 2026 (shoulder arthroplasty at Duke Health, knee at NYU Langone). It showcased handheld robotics at AAOS 2026. CORI-specific revenue is not broken out of the group.
2 signals name Smith+Nephew. Members see all of them, filtered by topic, source and date.
10 facts on file. Members see all of them with the source link.
Traction: deployment, production, commercials, progress. Capability: technology, positioning, firepower, leverage.
The segment's suppliers, constraints and risers, for members.
Smith+Nephew develops and sells the CORI Surgical System, a robotic-assisted platform for orthopedic surgery. Its medical robotics business qualifies as a medical and surgical robotics system. Smith+Nephew's CORI handheld robotic platform (within the LSE:SN group) covers revision knee, hip, and shoulder procedures in hospital and ASC settings, with CORI XT first clinical cases in June 2026 (shoulder arthroplasty at Duke Health, knee at NYU Langone). It showcased handheld robotics at AAOS 2026. CORI-specific revenue is not broken out of the group.
Smith+Nephew ranks 65 of 100 on the Robotics 100 (November 2026 edition) with a score of 81 out of 100, in Medical & surgical (Systems). Assessment by Frontier Tech Intelligence.
Intuitive Surgical (rank 1), Stryker (rank 29), Zimmer Biomet (rank 60), Procept BioRobotics (rank 88).
Smith+Nephew is based in Watford, England, United Kingdom. Stage: Established.
Subscribers see the full file, every signal, the live ranking and the questions the signals answer: where money moved, who controls the layer, where supply is constrained. $99 a month, 7-day trial. What Frontier Tech Intelligence is →